Protalix BioTherapeutics Inc(PLX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PLX Protalix BioTherapeutics Inc

交易中 11-15 15:18:50 EST

1.39

-0.02

-1.42%

最高1.41	最低1.33	成交量28.54万
今开1.37	昨收1.41	日振幅5.67%
总市值1.02亿	流通市值7,598万	总股本7,354万
成交额39.09万	换手率0.52%	流通股本5,466万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PLX","market":"US","secType":"STK","nameCN":"Protalix BioTherapeutics Inc","latestPrice":1.39,"timestamp":1731701908449,"preClose":1.41,"halted":0,"volume":285377,"delay":0,"floatShares":54659724,"shares":73542674,"eps":-0.201537,"marketStatus":"交易中","marketStatusCode":2,"change":-0.02,"latestTime":"11-15 15:18:50 EST","open":1.3714,"high":1.41,"low":1.33,"amount":390911.12686200003,"amplitude":0.056738,"askPrice":1.39,"askSize":387,"bidPrice":1.38,"bidSize":755,"shortable":3,"etf":0,"ttmEps":-0.201537,"exchange":"AMEX","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1731704400000},"adr":0,"listingDate":829022400000,"adjPreClose":1.41,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.4,"preClose":1.41,"latestTime":"09:09 EST","volume":570,"amount":803.858916,"timestamp":1731679749753},"postHourTrading":{"tag":"盘后","latestPrice":1.3993,"preClose":1.41,"latestTime":"19:58 EST","volume":20092,"amount":28446.1114,"timestamp":1731632329233},"volumeRatio":0.608039,"impliedVol":1.0892,"impliedVolPercentile":0.5992},"requestUrl":"/m/hq/s/PLX","defaultTab":"news","newsList":[{"id":"2483305419","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 早盘快速跳水5.67%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483305419","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483305419?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:45","pubTimestamp":1731685542,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时45分，Protalix Biotherapeutics, Inc. 股票出现波动，股价急速跳水5.67%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为3.26%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115234542971a6e68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115234542971a6e68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2483411804","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 急速上涨8.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483411804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483411804?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:35","pubTimestamp":1731594905,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时35分，Protalix Biotherapeutics, Inc. 股票出现异动，股价大幅拉升8.06%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为0.51%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422350595be2cde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422350595be2cde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX","ELAB","BK4183"],"gpt_icon":0},{"id":"2483123080","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 快速上涨5.83%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483123080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483123080?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:53","pubTimestamp":1731426780,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日23时53分，Protalix Biotherapeutics, Inc. 股票出现波动，股价大幅上涨5.83%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为0.46%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111223530098e421f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111223530098e421f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2481101016","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 快速上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101016?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:35","pubTimestamp":1731076514,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时35分，Protalix Biotherapeutics, Inc. 股票出现波动，股价快速拉升5.17%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Fortrea Holdings Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Matinas Biopharma Holdings, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为403.65%、20.45%、15.15%，振幅较大的相关个股有Cardiff Oncology, Inc.、Rigel Pharmaceuticals, Inc.、Anebulo Pharmaceuticals, Inc.，振幅分别为18.09%、16.52%、14.96%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223515971a55e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223515971a55e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2481955731","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 快速跳水6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481955731","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481955731?lang=zh_cn&edition=full","pubTime":"2024-11-07 04:45","pubTimestamp":1730925904,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日04时45分，Protalix Biotherapeutics, Inc. 股票出现异动，股价急速下跌6.15%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为0.55%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107044504a21dceb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107044504a21dceb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2480584015","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 早盘快速上涨5.60%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480584015","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480584015?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:05","pubTimestamp":1730732732,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时05分，Protalix Biotherapeutics, Inc. 股票出现异动，股价急速上涨5.60%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.00%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。该公司已经开发出用于治疗戈谢病的taliglucerase alfa。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110423053298e404da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110423053298e404da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2480884879","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 早盘大幅拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480884879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480884879?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:58","pubTimestamp":1730469507,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时58分，Protalix Biotherapeutics, Inc. 股票出现异动，股价大幅拉升5.13%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.70%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。该公司已经开发出用于治疗戈谢病的taliglucerase alfa。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101215827971a3dd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101215827971a3dd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2479453013","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 快速拉升5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479453013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479453013?lang=zh_cn&edition=full","pubTime":"2024-10-29 02:35","pubTimestamp":1730140542,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日02时35分，Protalix Biotherapeutics, Inc. 股票出现波动，股价快速上涨5.27%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Monte Rosa Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Eyepoint Pharmaceuticals, Inc.涨幅较大，Tc Biopharm  Plc、Genprex, Inc.、Monte Rosa Therapeutics, Inc.较为活跃，换手率分别为729.57%、364.25%、136.61%，振幅较大的相关个股有Monte Rosa Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为127.61%、87.13%、84.14%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029023543a1f2d5e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029023543a1f2d5e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2478167965","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 急速上涨5.83%报1.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478167965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478167965?lang=zh_cn&edition=full","pubTime":"2024-10-26 03:27","pubTimestamp":1729884420,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日03时27分，Protalix Biotherapeutics, Inc. 股票出现波动，股价快速上涨5.83%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Iterum Therapeutics Plc、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Iterum Therapeutics Plc较为活跃，换手率分别为862.57%、792.33%、425.14%，振幅较大的相关个股有Iterum Therapeutics Plc、Elevai Labs, Inc.、Qualigen Therapeutics, Inc.，振幅分别为102.56%、93.82%、91.58%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026032700ab749dc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026032700ab749dc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2474019653","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 临近午盘股价大涨5.00%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474019653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474019653?lang=zh_cn&edition=full","pubTime":"2024-10-11 23:34","pubTimestamp":1728660856,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日23时34分，Protalix Biotherapeutics, Inc. 股票出现波动，股价快速拉升5.00%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.95%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410112334169719fb65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410112334169719fb65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2473101521","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 股价大跌5.09%报1.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473101521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473101521?lang=zh_cn&edition=full","pubTime":"2024-10-07 22:32","pubTimestamp":1728311574,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日22时32分，Protalix Biotherapeutics, Inc. 股票出现波动，股价急速下跌5.09%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.21%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072232559719eaa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072232559719eaa1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2473997302","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 股价大涨6.93%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473997302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473997302?lang=zh_cn&edition=full","pubTime":"2024-10-05 04:15","pubTimestamp":1728072923,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日04时15分，Protalix Biotherapeutics, Inc. 股票出现异动，股价急速上涨6.93%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Entero Therapeutics Inc.、Cue Biopharma, Inc.涨幅较大，Aditxt, Inc.、Entero Therapeutics Inc.、Seelos Therapeutics, Inc.较为活跃，换手率分别为18096.52%、292.45%、108.51%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Entero Therapeutics Inc.、Aditxt, Inc.，振幅分别为133.33%、111.82%、77.84%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100504152398e3aa9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100504152398e3aa9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2468570601","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 早盘快速拉升5.50%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468570601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468570601?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:32","pubTimestamp":1726752774,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时32分，Protalix Biotherapeutics, Inc. 股票出现波动，股价急速拉升5.50%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为1043.90%、372.07%、72.69%，振幅较大的相关个股有Exicure, Inc.、Portage Biotech Inc.、Autolus Therapeutics Plc，振幅分别为54.59%、14.49%、12.66%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192132559719bd6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192132559719bd6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2462944370","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 下午盘急速跳水5.83%报0.911美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2462944370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462944370?lang=zh_cn&edition=full","pubTime":"2024-08-27 02:01","pubTimestamp":1724695301,"startTime":"0","endTime":"0","summary":"北京时间2024年08月27日02时01分，Protalix Biotherapeutics, Inc. 股票出现波动，股价急速下跌5.83%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为0.12%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082702014298e364cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082702014298e364cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2460717002","title":"Protalix Biotherapeutics, Inc. (De)2024财年第二财季实现净利润-2.20百万美元，同比减少111.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460717002","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460717002?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:05","pubTimestamp":1723997121,"startTime":"0","endTime":"0","summary":"8月19日，Protalix Biotherapeutics, Inc. 公布财报，公告显示公司2024财年第二财季净利润为-2.20百万美元，同比减少111.38%；其中营业收入为13.47百万美元，同比减少61.60%，每股基本收益为-0.03美元。从资产负债表来看，Protalix Biotherapeutics, Inc. 总负债62.96百万美元，其中短期债务21.87百万美元，资产负债比为1.46，流动比率为1.34。机构评级：截至2024年8月19日，当前有1家机构对Protalix Biotherapeutics, Inc. 目标价做出预测，其中目标均价为14.00美元，其中最低目标价为14.00美元，最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408190005319f363e6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408190005319f363e6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX"],"gpt_icon":0},{"id":"2459476705","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 早盘急速上涨5.02%报0.977美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459476705","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459476705?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:37","pubTimestamp":1723732661,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时37分，Protalix Biotherapeutics, Inc. 股票出现波动，股价大幅拉升5.02%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Cingulate Inc.、Tempest Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为5999.09%、1990.66%、486.23%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Tempest Therapeutics, Inc.、Cingulate Inc.，振幅分别为103.98%、79.83%、70.46%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815223741a1d473fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815223741a1d473fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2459717099","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 股价大跌5.77%报0.980美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459717099","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459717099?lang=zh_cn&edition=full","pubTime":"2024-08-14 22:11","pubTimestamp":1723644683,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日22时11分，Protalix Biotherapeutics, Inc. 股票出现波动，股价急速下跌5.77%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Newamsterdam Pharma Co Nv C/Wts 、Conduit Pharmaceuticals Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Genprex, Inc.、Conduit Pharmaceuticals Inc.、Viracta Therapeutics, Inc.较为活跃，换手率分别为82.50%、65.57%、48.41%，振幅较大的相关个股有Genprex, Inc.、Tc Biopharm  Plc、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为58.52%、49.86%、48.32%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814221123a1d4488a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814221123a1d4488a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2458340608","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 下午盘急速上涨5.00%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458340608","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458340608?lang=zh_cn&edition=full","pubTime":"2024-08-09 01:31","pubTimestamp":1723138266,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日01时31分，Protalix Biotherapeutics, Inc. 股票出现波动，股价快速上涨5.00%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为3.57%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Senti Biosciences, Inc.、Conduit Pharmaceuticals Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Aditxt, Inc.较为活跃，换手率分别为421.32%、296.15%、192.95%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Fibrobiologics, Inc.，振幅分别为128.24%、54.41%、45.58%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809013106a1d42805&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809013106a1d42805&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2457269808","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 急速上涨8.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457269808","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457269808?lang=zh_cn&edition=full","pubTime":"2024-08-07 23:32","pubTimestamp":1723044765,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日23时32分，Protalix Biotherapeutics, Inc. 股票出现异动，股价急速拉升8.91%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为1.95%。其相关个股中，Aditxt, Inc.、G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Aditxt, Inc.、Salarius Pharmaceuticals, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为4386.05%、1037.89%、326.10%，振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.，振幅分别为101.30%、69.66%、47.31%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080723324696824d1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080723324696824d1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2457212710","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 早盘快速拉升5.00%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457212710","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457212710?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:38","pubTimestamp":1722955089,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日22时38分，Protalix Biotherapeutics, Inc. 股票出现异动，股价大幅上涨5.00%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为2.15%。其相关个股中，Vbi Vaccines, Inc.、Alpha Tau Medical Ltd C/Wts 、Tenax Therapeutics, Inc.涨幅较大，Tenax Therapeutics, Inc.、Vbi Vaccines, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1142.22%、1021.29%、338.09%，振幅较大的相关个股有Vbi Vaccines, Inc.、Anew Medical Inc C/Wts 21/06/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为168.52%、70.73%、52.93%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806223809941fea5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806223809941fea5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.protalix.com","stockEarnings":[{"period":"1week","weight":0.2155},{"period":"1month","weight":0.3056},{"period":"3month","weight":0.4518},{"period":"6month","weight":0.2368},{"period":"1year","weight":0},{"period":"ytd","weight":-0.2079}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Protalix Biotherapeutics, Inc.最初于1992年4月在佛罗里达州注册成立，并于2016年3月在特拉华州重新注册成立。该公司是一家生物制药公司，专注于开发、生产和商业化由专有的ProCellEx植物细胞蛋白表达系统生产的重组治疗蛋白。该公司是第一家也是唯一一家获得FDA批准的通过植物细胞表达悬浮蛋白生产的公司。该公司独特的表达系统代表了一种以工业规模开发重组蛋白的新方法。该公司的战略重点是开发主要通过ProCellEx生产的定制复杂重组治疗性蛋白质，同时在生产前和生产后对蛋白质进行基因工程和化学修饰。该公司打算通过改进治疗蛋白的生物学特性（例如，糖基化、半衰期、免疫原性），进行此类工程设计和修改，以提供额外的临床益处。","yearOnYearQuotes":[{"month":1,"riseRate":0.705882,"avgChangeRate":0.101027},{"month":2,"riseRate":0.411765,"avgChangeRate":0.04937},{"month":3,"riseRate":0.294118,"avgChangeRate":-0.041326},{"month":4,"riseRate":0.555556,"avgChangeRate":0.048495},{"month":5,"riseRate":0.222222,"avgChangeRate":-0.026617},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.034136},{"month":7,"riseRate":0.388889,"avgChangeRate":-0.047615},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.016316},{"month":9,"riseRate":0.388889,"avgChangeRate":0.029946},{"month":10,"riseRate":0.388889,"avgChangeRate":-0.058909},{"month":11,"riseRate":0.388889,"avgChangeRate":-0.009557},{"month":12,"riseRate":0.352941,"avgChangeRate":-0.0158}],"exchange":"AMEX","name":"Protalix BioTherapeutics Inc","nameEN":"Protalix BioTherapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Protalix BioTherapeutics Inc(PLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Protalix BioTherapeutics Inc(PLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Protalix BioTherapeutics Inc,PLX,Protalix BioTherapeutics Inc股票,Protalix BioTherapeutics Inc股票老虎,Protalix BioTherapeutics Inc股票老虎国际,Protalix BioTherapeutics Inc行情,Protalix BioTherapeutics Inc股票行情,Protalix BioTherapeutics Inc股价,Protalix BioTherapeutics Inc股市,Protalix BioTherapeutics Inc股票价格,Protalix BioTherapeutics Inc股票交易,Protalix BioTherapeutics Inc股票购买,Protalix BioTherapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Protalix BioTherapeutics Inc(PLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Protalix BioTherapeutics Inc(PLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}